MyFinsight
Home
Blog
About
Net decrease in
cash, cash...
-$1,837K
(-142.03%↓ Y/Y)
Net loss/(gain) on
disposal of assets
-$248K
(-325.45%↓ Y/Y)
Accounts payable
$132K
(85.92%↑ Y/Y)
Stock-based compensation
expense
$104K
(-81.19%↓ Y/Y)
Prepaid expenses and
other current assets
-$35K
(89.03%↑ Y/Y)
Change in operating
lease right-of-use...
$3K
(-98.62%↓ Y/Y)
Change in finance lease
right-of-use assets
$1K
(-50.00%↓ Y/Y)
Net cash used in
operating activities
-$1,836K
(54.42%↑ Y/Y)
Net cash (used in)
provided by financing...
-$1K
(-100.03%↓ Y/Y)
Canceled cashflow
$523K
Net loss
-$1,326K
(80.79%↑ Y/Y)
Gain on the
termination of an operating...
$368K
Operating lease
liabilities
-$365K
(-0.55%↓ Y/Y)
Payments of finance lease
liability principal
$1K
(-50.00%↓ Y/Y)
Accrued expenses and
other liabilities
-$190K
(81.15%↑ Y/Y)
something is missing
-$110K
Back
Back
Cash Flow
Matinas BioPharma Holdings, Inc. (MTNB)
Matinas BioPharma Holdings, Inc. (MTNB)
source: myfinsight.com